List of works - Alessandro Ottaiano

A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report.

scientific article

Adjuvant treatment of malignant melanoma: where are we?

scientific article

Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors.

scientific article published on October 2016

Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment

scientific article published on 28 February 2017

Biological prognostic factors in adult soft tissue sarcomas.

scientific article

Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?

scientific article

CD40 activation as potential tool in malignant neoplasms.

scientific article

CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type

scientific article published on 05 April 2007

CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients

scientific article published on 29 November 2016

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol

scientific article published on 09 September 2019

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

scientific article published on 6 January 2016

Diffusion-Weighted MRI and Diffusion Kurtosis Imaging to Detect RAS Mutation in Colorectal Liver Metastasis

scientific article published on 26 August 2020

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.

scientific article published on 17 October 2013

Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study

scientific article published on 26 August 2020

Epidermal growth factor receptor as a major anticancer drug target

scientific article published on December 2006

Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer

scientific article published on 21 October 2020

Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma

scientific article published on 01 March 2005

Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome.

scientific article published on 21 November 2012

Finding markers for cancer stem cells in renal cell carcinoma: Looking beyond CD133 ⬇️

scientific article published on November 15, 2010

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.

scientific article published on 3 May 2018

First-line chemotherapy with fluorouracil and folinic acid for advanced colorectal cancer in elderly patients: a phase II study

scientific article published in March 2003

Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice ⬇️

scientific article published on 13 August 2019

Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples

article

Gastrointestinal non colorectal cancer. Do elderly patients need a specific management?

scientific article

Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials

scientific article

Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone-Responsive Human Breast Cancer.

scientific article published on 8 September 2016

Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells

scientific article published on 11 December 2004

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors

scientific article published on 16 October 2018

Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment

scientific article published on 01 May 2019

Metastatic colorectal cancer: role of target therapies and future perspectives

scientific article published on 8 February 2017

Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.

scientific article published in April 2017

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer

scientific article published on 18 July 2020

Obesity and cancer: biological links and treatment implications

scientific article published on 30 March 2017

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients

scientific article published on May 2006

Pathophysiology of Nociception and Rare Genetic Disorders with Increased Pain Threshold or Pain Insensitivity

scientific article published in 2022

Prognostic value of CD40 in adult soft tissue sarcomas.

scientific article

Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction

scientific article

Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy

scientific article published on 27 January 2016

Second-line intra-arterial chemotherapy in advanced pancreatic adenocarcinoma.

scientific article

Soluble interleukin-2 receptor in stage I–III melanoma

scientific article published on 01 February 2006

Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis

scientific article published on 16 July 2020

Trials on preoperative chemotherapy in resectable colorectal liver metastases need prospective evaluation of predictive factors of response.

scientific article published in August 2008

[Late complete response after long remission from treatment with FOLFIRI-aflibercept for metastatic colorectal cancer after progression to FOLFOX-bevacizumab].

scientific article published in August 2015

List of works by Alessandro Ottaiano

A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report.

Adjuvant treatment of malignant melanoma: where are we?

Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors.

Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment

Biological prognostic factors in adult soft tissue sarcomas.

Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?

CD40 activation as potential tool in malignant neoplasms.

CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type

CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

Diffusion-Weighted MRI and Diffusion Kurtosis Imaging to Detect RAS Mutation in Colorectal Liver Metastasis

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.

Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study

Epidermal growth factor receptor as a major anticancer drug target

Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer

Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma

Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome.

Finding markers for cancer stem cells in renal cell carcinoma: Looking beyond CD133 ⬇️

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.

First-line chemotherapy with fluorouracil and folinic acid for advanced colorectal cancer in elderly patients: a phase II study

Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice ⬇️

Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples

Gastrointestinal non colorectal cancer. Do elderly patients need a specific management?

Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials

Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone-Responsive Human Breast Cancer.

Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors

Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment

Metastatic colorectal cancer: role of target therapies and future perspectives

Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer

Obesity and cancer: biological links and treatment implications

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients

Pathophysiology of Nociception and Rare Genetic Disorders with Increased Pain Threshold or Pain Insensitivity

Prognostic value of CD40 in adult soft tissue sarcomas.

Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction

Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy

Second-line intra-arterial chemotherapy in advanced pancreatic adenocarcinoma.

Soluble interleukin-2 receptor in stage I–III melanoma

Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis

Trials on preoperative chemotherapy in resectable colorectal liver metastases need prospective evaluation of predictive factors of response.

[Late complete response after long remission from treatment with FOLFIRI-aflibercept for metastatic colorectal cancer after progression to FOLFOX-bevacizumab].